Free RAC-GS Exam Dumps Preview

A drug product presents degradation during the manufacturing process.
In addition to the amount, what information should be provided FIRST in order to use API overage?

Which of the following is an example of an acceptable statement for an advertisement of an approved arthritis medication?

Company X encounters challenges in the global life cycle management of its medical devices.

Which of the following Is MOST appropriate for improving product life cycle management?

Under which of the following circumstances would a regulatory authority require a more detailed premarket submission, a more rigorous audit, and/or the provision of more performance evaluation data than would normally apply to an IVD device of that risk class?

According to the ICH guideline on GMP for API,to which of the following is the MOST stringent requirement applied?

Which of the following BEST describes the content of the "Physical, Chemical, and Pharmaceutical Properties and Formulation" section of an IB?

Which of the following is the PRIMARY purpose of an audit report?

A global company is developing a sophisticated implantable medical device that is coated with antibiotics and biologics to enhance its efficacy. The product is marketed in Country X. where it is regulated as a medical device. The same product, without theantibiotics and biologics, is marketed as a medical device in Country Y. The company is proposing to start marketing the coated device in Country Y.

Which regulatory approach should the company propose?

A company receives multiple complaints regarding the text included on a recently launched product's label.

What action should the regulatory affairs professional take FIRST?

During face-to-face meetings with the regulatory authority to address submission issues, what is the BEST choice for the number of company representatives who should attend?

Which of the following changes to a drug product is MOST likely to be implemented without prior regulatory authority approval?

According to ICH, how many stability time points are normally required to establish a two-year shelf life for a product?

Which of the following criteria is MOST appropriate to define the animal species needed for the pre-clinical toxicity testing of a biotechnology product?

SOPs for preventive and corrective actions MUST include the procedure to eliminate which of the following?

Which of the following BEST describes the process of post-marketing surveillance for healthcare products?